Ex Parte Bacon et alDownload PDFPatent Trial and Appeal BoardNov 30, 201713416527 (P.T.A.B. Nov. 30, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/416,527 03/09/2012 David R. BACON 67979US003 4318 32692 7590 12/04/2017 3M INNOVATIVE PROPERTIES COMPANY PO BOX 33427 ST. PAUL, MN 55133-3427 EXAMINER PAULSON, SHEETAL R. ART UNIT PAPER NUMBER 3626 NOTIFICATION DATE DELIVERY MODE 12/04/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): LegalUSDocketing@mmm.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte DAVID R. BACON, LINDA L. MCINTYRE, DONNA C. SMITH, BENJAMIN M. TEMPLETON, and RICHARD H. WOLNIEWICZ Appeal 2016-005077 Application 13/416,5271 Technology Center 3600 Before MICHAEL C. ASTORINO, KENNETH G. SCHOPFER, and BRADLEY B. BAYAT, Administrative Patent Judges. BAYAT, Administrative Patent Judge. DECISION ON APPEAL Appellants appeal under 35 U.S.C. § 134 from the Examiner’s decision finally rejecting claims 1—31, which are all the pending claims in the application. We have jurisdiction under 35 U.S.C. § 6(b). SUMMARY OF DECISION We AFFIRM. 1 According to Appellants, “[t]he real party in interest is 3M Innovative Properties Company of St. Paul, Minnesota.” Appeal Brief 3 (“Appeal Br.,” filed Sept. 28,2015). Appeal 2016-005077 Application 13/416,527 STATEMENT OF THE CASE Claimed Subject Matter Appellants’ invention “relates to healthcare at medical facilities and to the documentation and editing of medical records.” Spec. 12. Claims 1,16, 30, and 31 are the independent claims on appeal. Independent claim 1, reproduced below with added formatting and bracketed notations, is illustrative of the subject matter on appeal and reads as follows: 1. A method of processing medical data via one or more computers, the method comprising: [(a)] identifying, via the one or more computers, a medical code within a medical record; [(b)] identifying, via the one or more computers, whether the medical code is one of a plurality of specified medical codes or one of a plurality of unspecified medical codes, wherein the specified medical codes are defined as sufficient to represent a medical condition to a payer and the unspecified medical codes are defined as requiring additional information to represent the medical condition to the payer; [(c)] if the medical code is one of the specified medical codes, avoiding display, via the one or more computers, of clinical edit options for the medical record without generating a query for further input by a physician, wherein the clinical edit options are used to determine whether a query for further input by a physician is warranted and allow a documentation specialist to edit one or more aspects of the medical record; [(d)] if the medical code is one of the unspecified medical codes, determining, via the one or more computers, whether one of a plurality of suppression codes associated with the medical code appears in the medical record, wherein the one of the plurality of suppression codes overrides the medical code by providing more specific information regarding the medical condition than the medical code; [(e)] if one of the suppression codes appears in the medical record, avoiding display, via the one or more computers, of the 2 Appeal 2016-005077 Application 13/416,527 clinical edit options for the medical record without generating the query for further input by the physician; [(f)] if one of the suppression codes does not appear in the medical record, searching for one or more key terms in the medical record via the one or more computers; [(g)] causing, via the one or more computers, display of the clinical edit options for the medical record based on the one or more key terms and based on whether the one or more key terms are present in the medical record; and [(h)] generating, via the one or more computers and for display, the query for further input by the physician based on the one or more key terms and based on whether the one or more key terms are present in the medical record. Appeal Br. 43^44, Claims App. Rejections I. Claims 1—31 are rejected under 35 U.S.C. § 101 as being directed to non-statutory subject matter. Answer 2—3 (“Ans.,” mailed Feb. 10, 2016). II. Claims 1—31 are rejected under 35 U.S.C. § 103(a) as unpatentable over Rao (US 7,725,330 B2, iss. May 25, 2010). Id. at 3-11. ANALYSIS Claim Construction To resolve the question of patentability, we begin by construing claim 1. During examination, claims are given their broadest reasonable interpretation consistent with the specification. See In re Am. Acad, of Sci. Tech Ctr., 367 F.3d 1359, 1364 (Fed. Cir. 2004). “Construing claims broadly during prosecution is not unfair to the applicant. . . because the 3 Appeal 2016-005077 Application 13/416,527 applicant has the opportunity to amend the claims to obtain more precise claim coverage.” Id. Here, claim 1 is directed to a computer implemented method of processing medical data, where the method includes several steps that only need to be performed if certain conditions precedent are met. See Appeal Br. 43 44, Claims App. Claim 1 recites, in pertinent part, (a) “identifying ... a medical code within a medical record” and (b) “identifying . . . whether the medical code is one of a plurality of specified medical codes or one of a plurality of unspecified medical codes.” Id. at 43. Claim 1 further recites: (c) if the medical code is one of the specified medical codes, avoiding display, via the one or more computers, of clinical edit options for the medical record without generating a query for further input by a physician, wherein the clinical edit options are used to determine whether a query for further input by a physician is warranted and allow a documentation specialist to edit one or more aspects of the medical record; (d) if the medical code is one of the unspecified medical codes, determining, via the one or more computers, whether one of a plurality of suppression codes associated with the medical code appears in the medical record, wherein the one of the plurality of suppression codes overrides the medical code by providing more specific information regarding the medical condition than the medical code; (e) if one of the suppression codes appears in the medical record, avoiding display, via the one or more computers, of the clinical edit options for the medical record without generating the query for further input by the physician', (f) if one of the suppression codes does not appear in the medical record, searching for one or more key terms in the medical record via the one or more computers .... Id. at 43 44 (emphasis added). In accord with our precedent, none of steps (d), (e), and (f) need to be satisfied to meet the method of claim 1. 4 Appeal 2016-005077 Application 13/416,527 See Ex Parte Schulhauser, Appeal 2013—007847, 2016 WL 6277792, at *3— 5 (PTAB Apr. 28, 2016) (precedential) (holding that in a method claim, a step reciting a condition precedent does not need to be performed if the condition precedent is not met). For example, if the medical code identified is a specified medical code, then the process avoids display of clinical edit options, as per step (c). Based on the language of the claim as written, the broadest reasonable interpretation of claim 1 encompasses an event in which the process ends after performance of process step (c), when the medical code is identified as a specified medical code. Thus, the remaining steps of claim 1 need not be performed because the performance of those steps requires identifying an unspecified medical code, as per step (d). With this interpretation in mind, we turn to the merits of the Examiner’s rejections. Rejection I—Non-Statutory Subject Matter Under 35U.S.C. § 101, an invention is patent-eligible if it claims a “new and useful process, machine, manufacture, or composition of matter.” 35U.S.C. § 101. The Supreme Court, however, has long interpreted § 101 to include an implicit exception: “[l]aws of nature, natural phenomena, and abstract ideas” are not patentable. See, e.g., Alice Corp. Pty. Ltd. v. CLS Banklnt’l, 134 S. Ct. 2347, 2354 (2014) (internal quotation marks and citation omitted). The Supreme Court, in Alice, reiterated the two-step framework previously set forth in Mayo Collaborative Services v. Prometheus Laboratories, Incorporated, 566 U.S. 66, 82—84 (2012), “for distinguishing patents that claim laws of nature, natural phenomena, and abstract ideas 5 Appeal 2016-005077 Application 13/416,527 from those that claim patent-eligible applications of those concepts.” Alice, 134 S. Ct. at 2355. The first step in that analysis is to “determine whether the claims at issue are directed to one of those patent-ineligible concepts.” Id. If the claims are not directed to a patent-ineligible concept, e.g., to an abstract idea, the inquiry ends. Otherwise, the inquiry proceeds to the second step where the elements of the claims are considered “individually and ‘as an ordered combination”’ to determine whether there are additional elements that “‘transform the nature of the claim’ into a patent-eligible application.” Id. (quoting Mayo, 566 U.S. 66, 79, 78). Applying the framework in Alice, and as the first step of that analysis, the Examiner determines that claims 1—31 are directed to “the abstract idea of creating medical codes for billing.” Final Action 2 (“Final Act.,” mailed Feb. 24, 2015). Claims 1—15 Appellants initially contend that a prima facie case has not been established because the Examiner has not cited to USPTO guidelines, judicial opinions, or any authority that establishes the claimed features are not directed to statutory subject matter. Appeal Br. 10-11; Reply Br. 2—3. But the Federal Circuit has made clear that “the prima facie case is merely a procedural device that enables an appropriate shift of the burden of production.” Hyatt v. Dudas, 492 F.3d. 1365, 1369 (Fed. Cir. 2007) (citing In re Oetiker, 977 F.2d 1443, 1445 (Fed. Cir. 1992)). 35 U.S.C. § 132 sets forth a general notice requirement whereby the applicant is notified of the reasons for a rejection together with such information as may be useful in judging the propriety of continuing with prosecution of the application. See, 6 Appeal 2016-005077 Application 13/416,527 e.g.,In re Jung, 637 F.3d 1356, 1362 (Fed. Cir. 2011). There is no requirement for the Examiner to cite examples from PTO guidelines or any additional case law to establish a prima facie case. Here, the Examiner provided adequate explanation to meet the notice requirement. See Final Act. 2—3; see also Ans. 11—14. The Examiner set forth the statutory basis of the rejection, applied Alice’s two-part framework, and sufficiently articulated reasoning in an informative manner (see supra), thus, meeting the notice requirement of 35 U.S.C. § 132. Chester v. Miller, 906 F.2d 1574, 1578 (Fed. Cir. 1990) (Section 132 “is violated when a rejection is so uninformative that it prevents the applicant from recognizing and seeking to counter the grounds for rejection.”). In fact, Appellants do not contend that they did not understand the Examiner’s rejection. To the contrary, Appellants’ understanding of the rejection is manifested by their substantive response to the rejection as set forth in their briefs. Under Alice step one, Appellants dispute the Examiner’s characterization of the abstract idea as being directed to creating medical codes for billing. Appeal Br. 12—13. Responding to Appellants’ arguments, the Examiner additionally determines: Identifying codes and determining whether it is specified or unspecified, and further categorizing the unspecified code into a suppression code or not a suppression code is similar to the abstract idea identified by the courts as comparing new and stored information and using rules to identify options; and further more similar to the abstract idea of identified by the courts as using categories to organize, store, and transmit information. The current claims compare the identified code from the medical record to the rules of specified or unspecified and identifying the 7 Appeal 2016-005077 Application 13/416,527 option to generate the query. The abstract idea here is not meaningfully different from the ideas found to be abstract in other cases before the Supreme Court. Ans. 12. In response to the Examiner’s additional determination of the abstract idea, Appellants argue that the claims are not directed to an idea of itself and “not similar to ‘comparing new and stored information and using rules to identify options’ or ‘using categories to organize, store, and transmit information.’” Reply Br. 3. “The ‘abstract idea’ step of the inquiry calls upon us to look at the ‘focus of the claimed advance over the prior art’ to determine if the claim’s ‘character as a whole’ is directed to excluded subject matter.” Affinity Labs of Texas, LLCv. DIRECTTV, LLC, 838 F.3d 1253, 1257 (Fed. Cir. 2016) (quoting Elec. Power Grp., LLC v. Alstom S.A., 830 F.3d 1350, 1353 (Fed. Cir. 2016); see also Enfish, LLC v. Microsoft Corp., 822 F.3d 1327, 1335 (Fed. Cir. 2016), quoted in Apple, Inc. v. Ameranth, Inc., 842 F.3d 1229, 1241 (Fed. Cir. 2016)). With respect to computer-enabled claimed subject matter, it can be helpful to determine whether “the claims at issue in [ ] can readily be understood as simply adding conventional computer components to well-known business practices” or not. Enfish, 822 F.3d at 1338. See also Affinity Labs of Texas, LLC v. DIRECTV, LLC, 838 F.3d at 1257. The question is whether the claims as a whole “focus on a specific means or method that improves the relevant technology” or are “directed to a result or effect that itself is the abstract idea and merely invoke generic processes and machinery.” McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1314 (Fed. Cir. 2016). 8 Appeal 2016-005077 Application 13/416,527 In this case, claim 1 as a whole is focused not on, for example, an improvement in computer technology but on a computer-implemented method of “processing medical data” that uses “one or more computers.” Cf. In re TLI Communications LLC Patent Litigation, 823 F.3d 607, 613 (Fed. Cir. 2016) (the claims’ focus “was not on an improved telephone unit or an improved server.”). Appellants’ Specification describes the problem and solution as follows: Unfortunately, medical records can be long, complicated, and sometimes incomplete. This can make the coding and review process very time consuming and difficult for a documentation specialist. The techniques and systems described herein can help to automate (or partially automate) the coding process associated with medical record review. In this manner, the process of coding medical records and verifying codes in medical records can be improved and/or simplified. The techniques may apply one or more rules to define when documentation for medical records is sufficient and when further review of the medical records is needed. The rules may define when the documentation specialist should review the medical records and may automate the process by avoiding the display of medical records to the documentation specialist when the documentation in the medical records is sufficient. The rules may further define when physician review is needed, and may automate the process by avoiding physician review when the documentation in the medical records is sufficient or when review by the documentation specialist may suffice prior to (and possibly in lieu of) physician review. Physician review of medical records is generally undesirable when it can be avoided as it is time consuming, labor intensive, and adds cost. Spec. 123 (emphasis added); see also id. 1 50 (“Manual review of CDI reference material can be difficult and time-consuming for a documentation specialist.”). Appellants also summarize the claimed subject matter on appeal as such. See Appeal Br. 3. 9 Appeal 2016-005077 Application 13/416,527 Unlike the claims found non-abstract in prior cases, claim 1 here uses generic computer technology for processing and coding of medical data, in which a medical code is identified within a medical record as either being a specified or an unspecified medical code, and rules are applied to define when documentation for medical records is sufficient (i.e., specified medical code) and when further review of the medical records may be needed (i.e., unspecified medical code), and do not recite an improvement to a particular computer technology. See, e.g., McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1314—15 (Fed. Cir. 2016) (finding claims not abstract because they “focused on a specific asserted improvement in computer animation”). The alleged advantages that Appellants tout do not concern an improvement to computer capabilities but instead relate to an alleged improvement in efficient, accurate, and cost effective processing (see supra) by automating the manual processing and coding of medical data,2 for which a computer is used as a tool in its ordinary capacity. As such, we determine that this is little more than the automation of the abstract idea of processing of medical data by applying one or more rules, which is consistent with the Examiner’s determination, and long prevalent in our healthcare system. See CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d 1366, 1372 (Fed. Cir. 2011) (finding that method claim 3’s steps are 2 The documentation specialist may be a nurse, clinician, administrative person, or any person given the task of reviewing medical records, and verifying or updating medical codes in the medical documentation. In general, the documentation specialist typically reviews medical records and ensures that the medical records include the correct medical codes associated with the medical tasks or medical conditions defined in the medical records. Spec. 122. 10 Appeal 2016-005077 Application 13/416,527 unpatentable mental processes in-part because each step could be performed in the human mind or by a human using a pen and paper). Moreover, the Federal Circuit has previously held other patent claims ineligible for reciting similar abstract concepts that merely collect, classify, and analyze data. For example, in In re TLI Communications LLC Patent Litigation, the concept of classifying data (an image) and storing it based on its classification was held abstract under step one. TLI Commc'ns, 823 F.3d 607, 611 (Fed. Cir. 2016). In Content Extraction, the concept of data collection, recognition, and storage was held abstract as well. Content Extraction & Transmission LLC v. Wells Fargo Bank, N.A., 776 F.3d 1343, 1347 (Fed. Cir. 2014). In BASCOM Global Internet Services, Inc. v. AT&T Mobility LLC, a claim to a “content filtering system for filtering content retrieved from an Internet computer network” was directed to an abstract idea. BASCOM, 827 F.3d 1341, 1348-49 (Fed. Cir. 2016). And in Electric Power Group, claims directed to collecting information, analyzing it, and displaying certain results of the collection and analysis were directed to an abstract idea. Elec. Power Grp., 830 F.3d at 1353—54 (“[W]e have treated analyzing information by steps people go through in their minds, or by mathematical algorithms, without more, as essentially mental processes within the abstract-idea category.”). Regarding claim 1 ’s recitation of specific data types (i.e., medical data), the Federal Circuit has recognized that limiting information to particular content does not change its character as information and is within the realm of abstract ideas. Id. at 1353 (“Information as such is an intangible.”). In light of these precedents, we 11 Appeal 2016-005077 Application 13/416,527 agree with the Examiner’s conclusion that claim 1 is “directed to” an abstract idea. Proceeding to the second step, the Examiner determines that: The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the additional elements or combination of elements in the claims, other than the abstract idea per se, amount to no more than a recitation of (a) generic computer structure that serves to perform generic computer functions that serve to merely link the abstract idea to a particular technological environment (i.e. computer, display, memory, processor, etc.); (b) functions that are well-understood, routine, and conventional activities previously known to the pertinent industry (i.e. identifying, determining, searching, causing, generating, etc.). Instructing one to “apply” an abstract idea and reciting no more than generic computer elements performing generic computer tasks does not make an abstract idea patent-eligible. Ans. 13-14. We also are not persuaded by Appellants’ contention that “[independent claim 1 is directed to a specific solution that is necessarily rooted in computer technology in order to overcome a problem specifically arising in the realm of reviewing medical records for proper coding and complete documentation,” similar to the decision in DDR Holdings, LLC v. Hotels.com, L.P., 773 F.3d 1245, 1257 (Fed. Cir. 2014). Reply Br. 5; see also Appeal Br. 14—15. We agree with the Examiner that Appellants’ reliance on DDR Holdings is misplaced. See Ans. 16. In DDR Holdings, the claims specified “how interactions with the Internet are manipulated to yield a desired result — a result that overrides the routine and conventional sequence of events ordinarily triggered by the 12 Appeal 2016-005077 Application 13/416,527 click of a hyperlink.” DDR Holdings, 773 F.3d at 1258. The court determined that these claims stand apart because they do not merely recite the performance of some business practice known from the pre- Internet world along with the requirement to perform it on the Internet. Instead, the claimed solution is necessarily rooted in computer technology in order to overcome a problem specifically arising in the realm of computer networks. Id. at 1257. Here, Appellants have not identified any purported “problem specifically arising in the realm of computer networks” solved by the invention. Cf. Intellectual Ventures ILLC v. Capital One Bank (USA), 792 F.3d 1363, 1371 (Fed. Cir. 2015) (“The patent claims here do not address problems unique to the Internet, so DDR has no applicability.”). Indeed, the manual processing, coding, and editing of medical records existed well before the Internet. In fact, claim 1 ’s process does not involve computer networks or an online environment. We also are unpersuaded by Appellants’ contention that [t]he claimed features thus illustrate an improvement to the technical field of medical record review and retrieving additional information by more accurately determining to present a query to a physician, and provide significantly more than the exception itself, and render the pending claims patent eligible under 35 U.S.C. § 101. Appeal Br. 20; Reply Br. 6—7. The only portion of the claimed method that could be considered “technological” is the use of generic computer hardware, i.e., the claimed “at least one or more computers” on which steps (a), (b) and (c) are performed, which is not enough to confer subject matter eligibility. See Alice Corp., 134 S. Ct. at 2358 (“[I]f a patent’s recitation of a computer amounts to a mere instruction to ‘implemen[t]’ an abstract idea 13 Appeal 2016-005077 Application 13/416,527 ‘on ... a computer,’ that addition cannot impart patent eligibility.”) (Quoting Mayo, 566 U.S. 66, 84). To the extent that claim 1 represents an improvement in the field of medical claims processing, we are not persuaded that the improvement is to any technology as opposed to an improvement to a general business practice. Evaluating representative claim 1, we agree with the Examiner that the claim lacks an “inventive concept” to transform the abstract idea into a patent-eligible application because those additional features must be more than well-understood, routine, and conventional activity. See Alice Corp., 134 S. Ct. at 2357 (“[CJlaims, which merely require generic computer implementation, fail to transform [an] abstract idea into a patent-eligible invention.”). Taking claim 1 ’s elements separately, the function performed by the computer in each step of the claimed process is purely conventional. Using a computer to identi fy and compare data, as recited in steps (a) and (b), embodies the most basic functions of a computer. And programming conventional software or hardware to apply rules, to display or avoid display of clinical edit options, is a routine and conventional practice. All of these computer functions are well-understood, routine, and conventional activities previously known to the industry7. In short, each step does no more than require a generic computer to perform conventional computer functions. See Spec. 196. The claim here also does no more than simply instruct the practitioner to implement the abstract idea on a generic computer. See Elec. Power Grp., 830 F.3d at 1355 (“Nothing in the claims, understood in light of the specification, requires anything other than off-the-shelf, conventional 14 Appeal 2016-005077 Application 13/416,527 computer, network, and display technology for gathering, sending, and presenting the desired information.”); see also Dealertrack, Inc. v. Huber, 674 F.3d 1315, 1333 (Fed. Cir. 2012) (“Simply adding a ‘computer aided’ limitation to a claim covering an abstract concept, without more, is insufficient to render [a] claim patent eligible.”)(Citation omitted). Accordingly, evaluating these claimed elements either individually or as an ordered combination, we conclude that claimed steps recite no more than routine steps involving generic computer components and conventional computer data processing activities to accomplish the well-known concept of processing, coding, and/or editing of clinical documentation. For the foregoing reasons, we sustain the Examiner’s rejection of claim 1 under 35U.S.C. § 101, including dependent claims 2—15, which are not argued separately. See Appeal Br. 20; see also Reply Br. 7. Claims 16—31 Independent claims 16, 30, and 31 are directed to a system, apparatus, and computer-readable storage medium encompassing substantially similar subject matter as claim 1. Appellants do not argue these claims in the Reply Brief, failing to address the Examiner’s additional determination of the abstract idea, as discussed above. A claim directed to a system, apparatus or computer recordable medium, despite its format, should be treated no differently from the comparable process claims held to be patent ineligible under § 101. As the Supreme Court has explained, the form of the claims should not trump basic issues of patentability. See Parker v. Flook, 98 S. Ct. 2522, 2527 (1978) (advising against a rigid reading of § 101 that “would make the determination of patentable subject matter depend simply on the 15 Appeal 2016-005077 Application 13/416,527 draftsman’s art and would ill serve the principles underlying the prohibition against patents for ‘ideas’ or phenomena of nature.”); see also Alice, 134 S. Ct. at 2358—59. As such, independent claims 16, 30, and 31, similar to independent claim 1, fail to satisfy the Alice framework and are directed to ineligible subject matter for the same reasons. Therefore, we sustain the rejection of independent claims 16, 30, and 31 under 35 U.S.C. § 101 for the same reasons as claim 1. We also sustain the rejection of dependent claims 17—29, which are not argued separately, for the same reasons as independent claim 16. See Appeal Br. 21. Rejection II—Obviousness Claims 1—8, 11—13, and 15 Based on our construction of claim 1, the Examiner here was able to make a prima facie case of obviousness as to claim 1 by providing evidence to show obviousness of steps (a), (b), and (c). The Examiner did not need to present evidence of obviousness as to the remaining method steps of claim 1 that are not required to be performed under a broadest reasonable interpretation of the claim (e.g., performance of conditional steps (d), (e), (f))- Appellants acknowledge that Rao discloses a method that includes identify[ing] ... the billing codes(s) that are actually recorded in the patient medical record,”’ as required by step (a), and ‘“compar[ing] the recorded billing code(s) with the extracted billing code(s) to determine whether the recorded billing codes are ‘correct’ or ‘incorrect’ and/or determine if the 16 Appeal 2016-005077 Application 13/416,527 patient medical record is ‘missing’ a billing code(s) that should be included,’” as required by step (b) of claim 1. Appeal Br. 26. Appellants argue that the Examiner’s rejection of claim 1 as being unpatentable over Rao is in error because: Rao does not disclose or suggest the claim feature of identifying, via one or more computers, whether a medical code is one of a plurality of specified medical codes or one of a plurality of unspecified medical codes, wherein the specified medical codes are defined as sufficient to represent a medical condition to a payer and the unspecified medical codes are defined as requiring additional information to represent the medical condition to the payer. Appeal Br. 26. In particular, Appellants dispute the Examiner’s interpretation of the claimed unspecified code “as a code that is missing from the billing record that should be included into the invoice due to the extraction of the medical information suggesting the inclusion of the billing code.” Id. (quoting Final Act. 12). Responding to Appellants’ argument, the Examiner modifies his position, and asserts that “Rao teaches the term ‘incorrect code,’ which is similar to the Appellants[’] word ‘unspecified code’” (Ans. 17), but Appellants do not contest this finding in the Reply Brief. As such, we are not apprised of error as to the Examiner’s finding as to step (b) of claim 1. Appellants do not dispute the Examiner’s findings as to step (c). Appellants’ additional arguments directed to the failure of the Examiner to demonstrate adequately that the remaining steps of claim 1 are rendered obvious are not commensurate with the broadest reasonable interpretation of claim 1 and are, thus, unpersuasive of error. 17 Appeal 2016-005077 Application 13/416,527 A proper interpretation of claim language, under the broadest reasonable interpretation of a claim during prosecution, must construe the claim language in a way that at least encompasses the broadest interpretation of the claim language for purposes of infringement. Based on the manner in which claim 1 is written, the method of Rao would literally infringe claim 1 by virtue of its performance of only steps (a), (b), and (c). See, e.g.,Applera Corp. v. Illumina, Inc., 375 Fed. Appx. 12, 21 (Fed. Cir. 2010) (unpublished) (affirming a district court’s interpretation of a method claim as including a step that need not be practiced if the condition for practicing the step is not met); Cybersettle, Inc. v. Nat'l Arbitration Forum, Inc., 243 Fed. Appx. 603, 607 (Fed. Cir. 2007) (unpublished) (“It is of course true that method steps may be contingent. If the condition for performing a contingent step is not satisfied, the performance recited by the step need not be carried out in order for the claimed method to be performed.”). For these reasons, we agree with the Examiner’s determination that Rao renders obvious the first three steps of claim 1. As such, we agree with the Examiner’s determination that claim 1 is unpatentable under 35 U.S.C. § 103(a). Accordingly, we sustain the rejection of claim 1, and claims 2—8, 11— 13, and 15, which are argued based on their dependency on claim 1. See Appeal Br. 32—33. Claims 9, 10, and 14 We are not persuaded by Appellants’ arguments as to claims 9, 10, and 14 because the steps recited in these claims need not be performed, as 18 Appeal 2016-005077 Application 13/416,527 they do not emanate from the performance of process steps (a), (b), and (c), as discussed above. Therefore, we sustain the rejection of these claims. Claims 16—31 We reach a different conclusion as to independent claims 16, 30, and 31, which are directed to different statutory classes of invention than process claim 1. System claim 16 and device claim 30 are directed to a machine, and computer-readable storage medium claim 31 is directed to an article of manufacture. Although Schulhauser dictates a broader construction of method claim 1, that same rationale does not necessarily apply to claims 16, 30, and 31, even though they recite functions that are substantially similar to the steps recited in the method of claim 1. The broadest reasonable interpretation of a system claim having structure that performs a function, which only needs to occur if a condition precedent is met, still requires structure for performing the function should the condition occur. This interpretation of the sy stem claim differs from the method claim because the structure ... is present in the system regardless of whether the condition is met and the function is actually performed. Unlike [the method claim], which is written in a manner that does not require all of the steps to be performed should the condition precedent not be met, [the system claim] is limited to the structure capable of performing all the recited functions. Schulhauser at 14. In assessing the rejection of independent claims 16, 30, and 31, we find that the Examiner errs by not making the requisite findings as to the structural elements of these claims. For example, in rejecting claim 16, the Examiner fails to make adequate factual findings as to the structure (i.e., a 19 Appeal 2016-005077 Application 13/416,527 processor configured to include and execute an editing module) that performs the recited functions. Instead, the Examiner asserts that “[sjince the teachings of Rao disclose the underlying process steps that constitute the methods of claims 1-5, it is respectfully submitted that they provide the underlying structural elements that perform the steps as well. As such, the limitations of claims 16-20 are rejected for the same reasons given above for claims 1-5.” Final Act. 9; Ans. 9. The Examiner similarly relies on Rao’s process to reject the apparatus of claim 30 and the medium of claim 31 without making adequate factual findings regarding the structure required by those claims. See Final Act. 10-11; see also Ans. 10—11. Due to the difference in scope of claims 16, 30, and 31, we find the Examiner’s reliance on findings for method claim 1 insufficient. Accordingly, because the Examiner has not presented adequate findings with respect to the structure of claims 16, 30, and 31, we cannot sustain the Examiner’s § 103(a) rejection over Rao of claims 16, 30, and 31. For the same reasons, we also do not sustain the Examiner’s rejection of claims 17— 29, which depend from independent claim 16/ 3 We note that system claim 29’s dependence from process claim 15 appears to be an inadvertent error because the same limitation is recited in claim 15. See Appeal 47, 52 (Claims App.). 20 Appeal 2016-005077 Application 13/416,527 DECISION The rejection of claims 1—31 under 35 U.S.C. § 101 is affirmed. The rejection of claims 1—15 under 35 U.S.C. § 103(a) is affirmed. The rejection of claims 16—31 under 35 U.S.C. § 103(a) is reversed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 21 Copy with citationCopy as parenthetical citation